Skip to content

Search

DiabHQ Community Reference Group

We’re looking for more community members to help with our exciting next phase of the DiabHQ mobile app

OPAL 2 study - with the Omnipod 5

The research team at Perth Children's Hospital and the Children's Diabetes Centre are looking for participants to be involved in the new Omnipod 5 study

Seed Grant recipients announced

The Rio Tinto Children’s Diabetes Centre; a Breakthrough T1D Centre of Excellence announces $40,000 in new round of seed grants for researchers dedicated to type 1 diabetes (T1D).

Capacity Building Grants now open

The Rio Tinto Children's Diabetes Centre; a Breakthrough T1D Centre of Excellence is excited to announce that the Capacity Building Grants are now open to all staff, students and collaborators across the Centre.

Dr Keely Bebbington awarded Stan Perron Charitable Foundation Fellowship

This fellowship is for her research that aims to improve mental health and wellbeing outcomes for young people and their families living with type 1 diabetes (T1D).

Digenic Congenital Hypogonadotropic Hypogonadism Due to Heterozygous GNRH1 p.R31C and AMHR2 p.G445_L453del Variants

A 28-year-old man with congenital hypogonadotropic hypogonadism (CHH) was found to be heterozygous for the GNRH1 p.R31C mutation, reported in the literature as pathogenic and dominant. The same mutation was found in his son at birth, but the testing of the infant at 64 days confirmed the hormonal changes associated with minipuberty.

A surge in serum mucosal cytokines associated with seroconversion in children at risk for type 1 diabetes

Autoantibodies to pancreatic islet antigens identify young children at high risk of type 1 diabetes. On a background of genetic susceptibility, islet autoimmunity is thought to be driven by environmental factors, of which enteric viruses are prime candidates.

An Assessment of Clinical Continuous Glucose Monitoring Targets for Older and High-Risk People Living with Type 1 Diabetes

To assess relationships between continuous glucose monitoring (CGM) time in range (TIR), 70-180 mg/dL, time below range (TBR), <70 mg/dL, time above range (TAR), >180 mg/dL, and glucose coefficient of variation (CV) in relation to currently recommended clinical CGM targets for older people, which recommend reduced TIR and TBR targets relative to the general type 1 diabetes population. 

'Artificial pancreas' helps ease diabetes burden

The Centre is currently involved in an international effort to develop revolutionary closed- loop 'artificial pancreas' technology. It is also leading a multi-centre Australian trial of these portable devices at home in young people with diabetes.

Four BrightSpark Fellowships awarded to early-career researchers at The Kids

Congratulations to four outstanding early-career researchers from The Kids Research Institute Australia, who have been awarded BrightSpark Foundation fellowships and project funding for 2026.